These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24065152)

  • 21. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
    Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
    Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes.
    Albu JB; Heilbronn LK; Kelley DE; Smith SR; Azuma K; Berk ES; Pi-Sunyer FX; Ravussin E;
    Diabetes; 2010 Mar; 59(3):627-33. PubMed ID: 20028945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of GM-CSF in adipose tissue inflammation.
    Kim DH; Sandoval D; Reed JA; Matter EK; Tolod EG; Woods SC; Seeley RJ
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1038-46. PubMed ID: 18765677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophages of the subcutaneous and omental fatty tissue in obese patients: Immunohistochemical phenotyping of M2 subtypes in relation to type 2 diabetes.
    Chylikova J; Dvorackova J; Cizkova K; Lacey H; Kamarad V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):133-137. PubMed ID: 30967686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.
    Billeter AT; Vittas S; Israel B; Scheurlen KM; Hidmark A; Fleming TH; Kopf S; Büchler MW; Müller-Stich BP
    Langenbecks Arch Surg; 2017 Sep; 402(6):901-910. PubMed ID: 28691147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.
    Eriksson-Hogling D; Andersson DP; Bäckdahl J; Hoffstedt J; Rössner S; Thorell A; Arner E; Arner P; Rydén M
    Int J Obes (Lond); 2015 Jun; 39(6):893-8. PubMed ID: 25666530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus.
    Hogan AE; Gaoatswe G; Lynch L; Corrigan MA; Woods C; O'Connell J; O'Shea D
    Diabetologia; 2014 Apr; 57(4):781-4. PubMed ID: 24362727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians.
    Ortega Martinez de Victoria E; Xu X; Koska J; Francisco AM; Scalise M; Ferrante AW; Krakoff J
    Diabetes; 2009 Feb; 58(2):385-93. PubMed ID: 19008342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.
    McGillicuddy FC; Harford KA; Reynolds CM; Oliver E; Claessens M; Mills KH; Roche HM
    Diabetes; 2011 Jun; 60(6):1688-98. PubMed ID: 21515850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes.
    Plomgaard P; Nielsen AR; Fischer CP; Mortensen OH; Broholm C; Penkowa M; Krogh-Madsen R; Erikstrup C; Lindegaard B; Petersen AM; Taudorf S; Pedersen BK
    Diabetologia; 2007 Dec; 50(12):2562-71. PubMed ID: 17928988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose tissue macrophage burden, systemic inflammation, and insulin resistance.
    Jia Q; Morgan-Bathke ME; Jensen MD
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E254-E264. PubMed ID: 32484712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression.
    Moschen AR; Molnar C; Geiger S; Graziadei I; Ebenbichler CF; Weiss H; Kaser S; Kaser A; Tilg H
    Gut; 2010 Sep; 59(9):1259-64. PubMed ID: 20660075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms for weight gain during blood glucose normalization].
    Laville M; Andreelli F
    Diabetes Metab; 2000 Jun; 26 Suppl 3():42-5. PubMed ID: 10945152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial.
    de Wit HM; Vervoort GM; Jansen HJ; de Galan BE; Tack CJ
    J Intern Med; 2016 Mar; 279(3):283-92. PubMed ID: 26553486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-fat diet action on adiposity, inflammation, and insulin sensitivity depends on the control low-fat diet.
    Benoit B; Plaisancié P; Awada M; Géloën A; Estienne M; Capel F; Malpuech-Brugère C; Debard C; Pesenti S; Morio B; Vidal H; Rieusset J; Michalski MC
    Nutr Res; 2013 Nov; 33(11):952-60. PubMed ID: 24176235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index.
    Raslová K; Tamer SC; Clauson P; Karl D
    Clin Drug Investig; 2007; 27(4):279-85. PubMed ID: 17358100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.
    Olsson PO; Lindström T
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):272-7. PubMed ID: 12442064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.